Denosumab as a Bridge to Surgery in a Patient with Severe Hypercalcemia Due to Primary Hyperparathyroidism in the Setting of Renal Dysfunction

Documenti analoghi

• Denosumab for management of severe hypercalcemia in primary hyperparathyroidism
  di: Eremkina, Anna, et al.
  Pubblicazione: (2020)
• Myelofibrosis and Pancytopenia Associated With Primary Hyperparathyroidism
  di: Rajan, Remya, et al.
  Pubblicazione: (2020)
• Trabecular Bone Score—An Emerging Tool in the Management of Osteoporosis
  di: Rajan, Remya, et al.
  Pubblicazione: (2020)
• Hypercalcemia due to hyperparathyroidism treated with a somatostatin analogue.
  di: Miller, D, et al.
  Pubblicazione: (1991)
• Diabetes due to recurrent pancreatitis secondary to hypercalcemia due to primary hyperparathyroidism
  di: Sumit Kumar Chakrabarti, et al.
  Pubblicazione: (2013-01-01)